We are a branded IPR-based pharmaceutical Company focusing on frontier markets...
Our purpose is to bring high-quality every-day medicines within the reach of populations...
Over the years, we have geared ourselves to create a meaningful business ...
Meet our leadership team that guides us
through all our business decisions...
Policies & disclosures
At Balaxi, our business strategies are responsible for creating a portfolio
We focus on bringing essential medicines within the reach of populations
At Balaxi, we have a comprehensive portfolio consisting of over 300
Our current established markets are Angola, Guatemala, and Dominican
Know how we manage distributions
across our markets...
Locate our offices across
Be a part of Balaxi and grow
Spreading awareness of our products
through our promotional campaigns...
Know about us in detail through our
At Balaxi, we constantly create a work environment that encourages ...
At Balaxi, we understand the importance of healthy employee relations...
Join us and become a Balaxite...
Intimation of AGM through VC and OAVM
Q1 Results FY 2021-22
Q4 and year ended Results FY 2020-21
Q3 Result FY 2020-21
NA Board Meeting Intimation Q3 FY 2020-21
Board Meeting Intimation (Q2 FY 2020-21)
Q1 Results (FY 2020-21)
Q1 Board Meeting Intimation
Results for Q4 and Year ended March 31, 2020
Q4 Board Meeting Intimation(FY 2019-20)
Q3 Results 20120
2019 Q1 Board Meeting Notice
EGM Notice Corrigendum
IEPF Transfer 2019-20
Q4 Results 2018-2019
Q4 Board Intimation 2019
Q3 (2018) Results
Q3 (2018) Board Intimation
Q2 Results 2018
75th AGM Notice
Advertisement for Completion of Postal Ballot Notice-2018
Q3 Results Board Meeting Intimation